A01N59/06

Mollusc Barrier
20230270055 · 2023-08-31 ·

Use of a composition as a barrier to molluscs is disclosed. The composition comprises a combustion product or an alkaline material and is in granular form. The granular composition may be effective and long-acting in such a use due to improved weather resistance compared to loose combustion product or alkaline material. A method of producing such a granular composition comprising a combustion product or an alkaline material and a barrier method preventing access to plants by molluscs with said granular composition comprising a combustion product or an alkaline material are also disclosed. A granular composition comprising at least 98 wt % of a combustion product or an alkaline material, wherein at least 98% of the granules have a size of from 0.5 to 10.0 mm is also disclosed.

Mollusc Barrier
20230270055 · 2023-08-31 ·

Use of a composition as a barrier to molluscs is disclosed. The composition comprises a combustion product or an alkaline material and is in granular form. The granular composition may be effective and long-acting in such a use due to improved weather resistance compared to loose combustion product or alkaline material. A method of producing such a granular composition comprising a combustion product or an alkaline material and a barrier method preventing access to plants by molluscs with said granular composition comprising a combustion product or an alkaline material are also disclosed. A granular composition comprising at least 98 wt % of a combustion product or an alkaline material, wherein at least 98% of the granules have a size of from 0.5 to 10.0 mm is also disclosed.

Citrate perhydrates and uses thereof

The invention relates to citrate perhydrates and to the uses of citrate perhydrates, in particular as biocides, in particular pesticides, more particularly phytopharmaceuticals.

NITRIC OXIDE-RELEASING ANTIBACTERIAL COMPOUNDS, FORMULATIONS, AND METHODS PERTAINING THERETO

Several embodiments of NO releasing compounds are disclosed. In some embodiments, the structures are covalently modified to store and release nitric oxide. Some embodiments pertain to methods of making and use of these structures. The compounds may be tailored to release nitric oxide in a controlled manner and can be useful, for example, for treating or preventing microbial infections, or reducing the microbial load of a microbial infection.

Antimicrobial Prosthetic Liner
20230263643 · 2023-08-24 ·

An antimicrobial prosthetic liner having an exterior fabric layer and an inner layer comprising a thermoplastic and further incorporating evenly distributed nanoparticles of certain metal oxide nanoparticles in an amount ranging from 2%-6% weight per weight and ranging in size from between 5 nanometers and 100 nanometers in diameter, most preferably 20 nanometers in diameter. Preferably, the metal oxide nanoparticles used are titanium dioxide and zinc oxide. Copper oxide, magnesium oxide, aluminum hydroxide as well as metal nanoparticles such as gold nanoparticles and silver nanoparticles may also be used to provide antimicrobial effects.

Antimicrobial Prosthetic Liner
20230263643 · 2023-08-24 ·

An antimicrobial prosthetic liner having an exterior fabric layer and an inner layer comprising a thermoplastic and further incorporating evenly distributed nanoparticles of certain metal oxide nanoparticles in an amount ranging from 2%-6% weight per weight and ranging in size from between 5 nanometers and 100 nanometers in diameter, most preferably 20 nanometers in diameter. Preferably, the metal oxide nanoparticles used are titanium dioxide and zinc oxide. Copper oxide, magnesium oxide, aluminum hydroxide as well as metal nanoparticles such as gold nanoparticles and silver nanoparticles may also be used to provide antimicrobial effects.

METHOD FOR MAKING MESOPOROUS MAGNESIUM HYDROXIDE NANOPLATES, AN ANTIBACTERIAL COMPOSITION, AND A METHOD OF REDUCING NITROAROMATIC COMPOUNDS

A method for producing mesoporous magnesium hydroxide nanoplates involving solvothermal treatment of a solution of a magnesium salt, a base, a glycol, and water is disclosed. The method does not use a surfactant or template in the solvothermal treatment. The method yields mesoporous nanoparticles of magnesium hydroxide having a plate-like morphology with a diameter of 20 nm to 100 nm, a mean pore diameter of 2 to 10 nm, a surface area of 50 to 70 m.sup.2/g, and a type-III nitrogen adsorption-desorption BET isotherm with a H3 hysteresis loop. An antibacterial composition containing the mesoporous magnesium hydroxide nanoplates is also disclosed. A method for reducing nitroaromatic compounds with a reducing agent and the mesoporous magnesium hydroxide nanoplates as a catalyst is also disclosed.

METHOD FOR MAKING MESOPOROUS MAGNESIUM HYDROXIDE NANOPLATES, AN ANTIBACTERIAL COMPOSITION, AND A METHOD OF REDUCING NITROAROMATIC COMPOUNDS

A method for producing mesoporous magnesium hydroxide nanoplates involving solvothermal treatment of a solution of a magnesium salt, a base, a glycol, and water is disclosed. The method does not use a surfactant or template in the solvothermal treatment. The method yields mesoporous nanoparticles of magnesium hydroxide having a plate-like morphology with a diameter of 20 nm to 100 nm, a mean pore diameter of 2 to 10 nm, a surface area of 50 to 70 m.sup.2/g, and a type-III nitrogen adsorption-desorption BET isotherm with a H3 hysteresis loop. An antibacterial composition containing the mesoporous magnesium hydroxide nanoplates is also disclosed. A method for reducing nitroaromatic compounds with a reducing agent and the mesoporous magnesium hydroxide nanoplates as a catalyst is also disclosed.

METHOD FOR MAKING MESOPOROUS MAGNESIUM HYDROXIDE NANOPLATES, AN ANTIBACTERIAL COMPOSITION, AND A METHOD OF REDUCING NITROAROMATIC COMPOUNDS

A method for producing mesoporous magnesium hydroxide nanoplates involving solvothermal treatment of a solution of a magnesium salt, a base, a glycol, and water is disclosed. The method does not use a surfactant or template in the solvothermal treatment. The method yields mesoporous nanoparticles of magnesium hydroxide having a plate-like morphology with a diameter of 20 nm to 100 nm, a mean pore diameter of 2 to 10 nm, a surface area of 50 to 70 m.sup.2/g, and a type-III nitrogen adsorption-desorption BET isotherm with a H3 hysteresis loop. An antibacterial composition containing the mesoporous magnesium hydroxide nanoplates is also disclosed. A method for reducing nitroaromatic compounds with a reducing agent and the mesoporous magnesium hydroxide nanoplates as a catalyst is also disclosed.

ANTIFOULANT MARINE STRUCTURES COMPOSITIONS AND METHODS THEREOF
20220142153 · 2022-05-12 ·

The invention relates to antifoulant compositions comprising i) an antimicrobial composition and ii) one or more polymers as well as antifoulant compositions comprising i) an antimicrobial composition and ii) one or more composite materials. The invention includes the antifoulant compositions, methods for making the antifoulant compositions, and methods of reducing presence of a fouling organism on a surface of a composition utilizing the antifoulant compositions.